Literature DB >> 10448083

The significance of the homozygous CYP2A6 deletion on nicotine metabolism: a new genotyping method of CYP2A6 using a single PCR-RFLP.

K Kitagawa1, N Kunugita, T Katoh, M Yang, T Kawamoto.   

Abstract

A convenient and specific CYP2A6 genotyping method was developed in this study. This method consisting of a single PCR-RFLP is capable of resolving the genotype into either CYP2A6*1 (wild type), CYP2A6*2, or CYP2A6*3. Among 252 Japanese persons genotyped, 241 were genotyped as the wild type, 1 as an unknown variant, and none as either CYP2A6*2 or CYP2A6*3. A homozygous deletion was found in the 10 remaining subjects. To clarify the metabolic significance of this deletion in the whole human body, urinary cotinine, the principal metabolite of nicotine, was analyzed subsequent to smoking. Cumulated urinary cotinine excretion in the homozygously CYP2A6-deleted individuals was about one-seventh compared to the control group (wild type). This study provides a firm experimental basis for correlating genotypic characterization of CYP2A6 with phenotypic expression of nicotine metabolism. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448083     DOI: 10.1006/bbrc.1999.1182

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  Polymorphisms of CYP2A6 and its practical consequences.

Authors:  H Raunio; A Rautio; H Gullstén; O Pelkonen
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

Review 2.  Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio.

Authors:  Cheyenne E Allenby; Kelly A Boylan; Caryn Lerman; Mary Falcone
Journal:  J Neuroimmune Pharmacol       Date:  2016-02-12       Impact factor: 4.147

3.  Applications of CYP-450 expression for biomonitoring in environmental health.

Authors:  Ho-Sun Lee; Mihi Yang
Journal:  Environ Health Prev Med       Date:  2008-02-28       Impact factor: 3.674

4.  Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancer.

Authors:  Chikako Kiyohara; Taro Shirakawa; Julian M Hopkin
Journal:  Environ Health Prev Med       Date:  2002-05       Impact factor: 3.674

5.  Relation between cotinine in the urine and indices based on self-declared smoking habits.

Authors:  Akiko Tsutsumi; Jun Kagawa; Yuko Yamano; Toshio Nakadate; Satoru Shimizu
Journal:  Environ Health Prev Med       Date:  2002-01       Impact factor: 3.674

6.  Nicotine Metabolism and Smoking: Ethnic Differences in the Role of P450 2A6.

Authors:  Sharon E Murphy
Journal:  Chem Res Toxicol       Date:  2016-11-22       Impact factor: 3.739

Review 7.  PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6.

Authors:  Ellen M McDonagh; Catherine Wassenaar; Sean P David; Rachel F Tyndale; Russ B Altman; Michelle Whirl-Carrillo; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-09       Impact factor: 2.089

8.  Enzyme-linked immunosorbent assay of nicotine metabolites.

Authors:  Akiko Matsumoto; Toshihiro Ino; Mitsuhiro Ohta; Tetsuya Otani; Sachiko Hanada; Atsushi Sakuraoka; Akane Matsumoto; Masayoshi Ichiba; Megumi Hara
Journal:  Environ Health Prev Med       Date:  2010-01-08       Impact factor: 3.674

9.  Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema.

Authors:  N Minematsu; H Nakamura; M Iwata; H Tateno; T Nakajima; S Takahashi; S Fujishima; K Yamaguchi
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

10.  CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking.

Authors:  Wiratchanee Mahavorasirikul; Wichittra Tassaneeyakul; Soisagwan Satarug; Ronnatrai Reungweerayut; Chacrin Na-Bangchang; Kesara Na-Bangchang
Journal:  Eur J Clin Pharmacol       Date:  2008-12-13       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.